Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Synthesis and structure-activity relationships of N - (3 - (1H-imidazol-2-yl) phenyl) - 3-phenylpropionamide derivatives as a novel class of covalent inhibitors of p97/VCP ATPase' [ Eur. J. Med. Chem. 248 (2023) 115094].

European journal of medicinal chemistry·2026
Same author

Screens and Youth Sleep.

JAMA pediatrics·2026
Same author

Highly ionic-dispersed oxygen electrode for reversible proton ceramic electrochemical cells.

Nature communications·2026
Same author

Dictamnine Inhibits WNT Pathway and EMT Progression in Prostate Cancer and Remodels the Tumor Microenvironment.

Cancers·2026
Same author

Gut microbiota and macrophage crosstalk: implications for colitis-associated colorectal cancer.

Frontiers in cellular and infection microbiology·2026
Same author

Impact of Order Set Design on Pediatric Intravenous Fluid Guideline Adherence: A National Study.

Hospital pediatrics·2026

Related Experiment Video

Updated: Apr 21, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.1K

eMBI: Boosting Gene Expression-based Clustering for Cancer Subtypes.

Zheng Chang1, Zhenjia Wang1, Cody Ashby2

  • 1School of Mathematics, Shandong University, Jinan, Shandong, China.

Cancer Informatics
|November 7, 2014
PubMed
Summary

Enhanced Maximum Block Improvement (eMBI) effectively identifies cancer subtypes from gene expression data. This new method improves accuracy and efficiency over existing techniques like Maximum Block Improvement (MBI) and hierarchical clustering.

Keywords:
biclusteringcancer classificationconsensus clusteringiterative methodmatrix factorizationmicroarray analysis

More Related Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.5K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

8.0K

Related Experiment Videos

Last Updated: Apr 21, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.1K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.5K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

8.0K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Identifying cancer subtypes from gene expression data is crucial for personalized medicine.
  • Matrix factorization techniques, like Maximum Block Improvement (MBI), offer a way to find patterns related to subtypes.
  • Existing MBI methods have limitations when applied to complex cancer gene expression datasets.

Purpose of the Study:

  • To develop an improved matrix factorization method for more effective cancer subtype identification.
  • To enhance the Maximum Block Improvement (MBI) algorithm for better accuracy, robustness, and speed.

Main Methods:

  • Developed enhanced strategies to improve the Maximum Block Improvement (MBI) algorithm.
  • Created a new program named enhanced MBI (eMBI).
  • Tested eMBI on multiple cancer gene expression profiling datasets.

Main Results:

  • eMBI demonstrated significant improvements over MBI in cancer subtype prediction accuracy and robustness.
  • eMBI achieved a faster running time compared to MBI.
  • eMBI outperformed non-negative matrix factorization (NMF) and hierarchical clustering in performance.

Conclusions:

  • The enhanced MBI (eMBI) program is a more effective and efficient tool for identifying cancer subtypes.
  • eMBI offers substantial advantages over existing matrix factorization and clustering methods for cancer data analysis.
  • This advancement facilitates more precise and efficient patient treatments based on distinct cancer subtypes.